The Conversation (0)
RepliCel Life Sciences Lands Commitment for Key Investment Partnership
Jan. 16, 2018 04:08PM PST
Life Science Investing NewsRepliCel Life Sciences (TSX:RP), announced it has signed a Binding Term Sheet with YOFOTO (China) Health Industry Co. to form a strategic partnership in Greater China. As quoted from the press release: The deal reflected in the Term Sheet, involves an up-front investment of USD $6,500,000 and potential pre-commercial, non-dilutive milestones payments of another USD $2,800,000. Additionally, the …
RepliCel Life Sciences (TSX:RP), announced it has signed a Binding Term Sheet with YOFOTO (China) Health Industry Co. to form a strategic partnership in Greater China.
As quoted from the press release:
The deal reflected in the Term Sheet, involves an up-front investment of USD $6,500,000 and potential pre-commercial, non-dilutive milestones payments of another USD $2,800,000. Additionally, the Term Sheet commits YOFOTO to another USD $1,000,000 in potential post-commercial non-dilutive milestone payments, several million in dedicated program funding in Greater China over the next five years, and future royalty payments calculated on gross product sales in the Territory.